Cocrystal Pharma closes $4.7M registered direct offering with warrant coverage

Cocrystal Pharma, Inc.

Gross proceeds of ~$4.75M from sale of 2,764,710 shares at $1.70 each.
Warrants issued to purchase 5,529,420 shares at $1.50, potential additional $8.3M.
Net proceeds for working capital and antiviral drug development.
H.C. Wainwright acted as placement agent; warrants expire 24 months after resale registration effective.

item 1.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.